Page last updated: 2024-11-01

nomifensine and Acute Confusional Senile Dementia

nomifensine has been researched along with Acute Confusional Senile Dementia in 2 studies

Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guzmán-Ramos, K1
Moreno-Castilla, P1
Castro-Cruz, M1
McGaugh, JL1
Martínez-Coria, H1
LaFerla, FM1
Bermúdez-Rattoni, F1
Maletta, GJ1

Other Studies

2 other studies available for nomifensine and Acute Confusional Senile Dementia

ArticleYear
Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
    Learning & memory (Cold Spring Harbor, N.Y.), 2012, Sep-14, Volume: 19, Issue:10

    Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brai

2012
Medications to modify at-home behavior of Alzheimer's patients.
    Geriatrics, 1985, Volume: 40, Issue:12

    Topics: Aged; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Behavior;

1985